ARVO 2022: Anti-VEGF Therapy Delays During COVID-19 Pandemic Lockdown Caused Greater Loss in Visual Acuity
Patient and delivery system factors influenced treatment and visit delays in neovascular age-related macular degeneration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.